Zevra Therapeutics Inc.

NASDAQ: ZVRA · Real-Time Price · USD
9.51
0.23 (2.48%)
At close: Aug 21, 2025, 3:59 PM
9.50
-0.11%
After-hours: Aug 21, 2025, 07:11 PM EDT

Zevra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
2.64M -91.99M -105.51M -84.92M -65.75M -50.9M -46.05M -39.92M -32.49M -51.45M -41.54M -35.23M -30.37M -123K -8.55M -10.71M -11.96M -17.3M
Depreciation & Amortization
6.57M 6.48M 6.39M 5.53M 3.97M 2.49M 1.01M 519K 855K 958K 944K 708K 375K 258K 257K 259K 261K 265K
Stock-Based Compensation
15.73M 15.9M 14.91M 13.85M 9.1M 7.22M 6.04M 4.04M 3.56M 4.32M 4.29M 4.16M 3.87M 2.68M 2.44M 2.07M 1.83M 2.14M
Other Working Capital
3.56M 3.09M 1.03M 2.31M 2.27M 1.66M 3.63M 8.47M 8.34M 6.22M 3.03M -698K -3.18M -1.22M -10.84M -9.46M -8.39M -10.49M
Other Non-Cash Items
-58.61M 14.58M 14.55M 7.55M 5.75M 7.36M 10.4M 5.28M -307K 17.86M 18.05M 18.25M 18.14M 389K 460K 2.07M 3.77M 5.67M
Deferred Income Tax
n/a n/a n/a -6.63M -12.19M -10.82M -10.82M -4.19M 1.37M n/a n/a -66K -398K -717K 16.2M 16.38M 16.85M 17.23M
Change in Working Capital
-12.54M -6.7M n/a -4.95M 3.05M -1.35M 5.88M 12.43M 3.2M 9.39M -466K -2.93M -2.86M 7.05M -357K 158K 1.14M -10.49M
Operating Cash Flow
-46.21M -61.72M -69.67M -69.57M -56.06M -45.66M -33.53M -21.84M -23.81M -19.28M -18.72M -15.1M -11.23M 9.54M 10.44M 10.23M 11.91M -2.5M
Capital Expenditures
-312K -99K n/a -72K -244K -267K -296K -258K -114K -106K -93K -76K -52K -118K -102K -111K -107K -22K
Cash Acquisitions
n/a n/a n/a -30.4M 13.88M -20.12M -20.12M 11.61M -32.67M -12.77M -12.77M -14.09M -14.09M n/a n/a n/a n/a n/a
Purchase of Investments
-213.67M -63.44M -41.29M -1.26M -13.68M -13.49M -45.81M -69.95M -16.17M -36.23M -22.54M -39.25M -39.25M -19.25M -15.42M n/a n/a n/a
Sales Maturities Of Investments
40.71M 28.21M 25M 40.42M 39.91M 73.91M 59.12M 42.17M 32.98M n/a n/a 1.32M 1.02M n/a n/a n/a n/a n/a
Other Investing Acitivies
158.92M 8.92M -5.87M -14.79M -59.08M -25.08M -27.81M -29.14M 15.45M -18.55M -4.86M -18.95M -19.25M -19.25M -15.42M n/a n/a n/a
Investing Cash Flow
-14.35M -26.41M -22.16M -6.11M -19.21M 14.96M -17.39M -28.04M 16.69M -50.43M -36.72M -52.09M -52.37M -19.37M -15.52M -111K -107K -22K
Debt Repayment
-16.66M -372K n/a 15.19M 41.4M 24.78M 24.89M 25.99M -215K 12.91M 12.78M 12.77M 12.75M -122K -38.1M -38.14M -38.17M -36.18M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -3.45M -3.45M -3.45M -3.45M -4.72M -7.54M -7.54M -7.54M -2.81M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
83.07M 82.18M 82.18M -797K -889K 1.27M 858K 604K 197K -340K 75K 290K 2.66M 41.74M 104.73M 104.79M 102.82M 62.91M
Financial Cash Flow
68.55M 82.5M 82.11M 86.32M 47.81M 33.43M 28.46M 23.2M -3.46M 9.4M 8.35M 5.74M 8.09M 34.02M 113.11M 115.93M 113.94M 76.01M
Net Cash Flow
8.45M -5.51M -9.26M 10.77M -26.94M 2.67M -22.42M -26.79M -10.58M -60.03M -46.88M -61.44M -55.52M 24.19M 108.02M 126.05M 125.74M 73.48M
Free Cash Flow
-46.53M -61.82M -69.67M -69.64M -56.3M -45.92M -33.83M -22.1M -23.92M -19.38M -18.81M -15.18M -11.29M 9.42M 10.34M 10.12M 11.8M -2.52M